709 related articles for article (PubMed ID: 15285001)
21. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
22. Lymphoproliferative diseases and hepatitis C virus infection.
Hausfater P; Rosenthal E; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
24. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Saadoun D; Bieche I; Authier FJ; Laurendeau I; Jambou F; Piette JC; Vidaud M; Maisonobe T; Cacoub P
Arthritis Rheum; 2007 Apr; 56(4):1315-24. PubMed ID: 17393409
[TBL] [Abstract][Full Text] [Related]
25. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
27. [Hematologic syndromes in hepatitis C virus infection].
Kryczka W; Kisiel E
Przegl Lek; 2000; 57(11):672-5. PubMed ID: 11293218
[TBL] [Abstract][Full Text] [Related]
28. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
[TBL] [Abstract][Full Text] [Related]
29. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
30. The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.
Landau DA; Rosenzwajg M; Saadoun D; Klatzmann D; Cacoub P
Ann Rheum Dis; 2009 Mar; 68(3):337-44. PubMed ID: 18434450
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia.
Karlsberg PL; Lee WM; Casey DL; Cockerell CJ; Cruz PD
Arch Dermatol; 1995 Oct; 131(10):1119-23. PubMed ID: 7574826
[TBL] [Abstract][Full Text] [Related]
32. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.
Simula MP; Caggiari L; Gloghini A; De Re V
Ann N Y Acad Sci; 2007 Sep; 1110():121-30. PubMed ID: 17911427
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection, cryoglobulinaemia, and beyond.
Sansonno D; Carbone A; De Re V; Dammacco F
Rheumatology (Oxford); 2007 Apr; 46(4):572-8. PubMed ID: 17317717
[TBL] [Abstract][Full Text] [Related]
34. Management of hepatitis C virus-related mixed cryoglobulinemia.
Iannuzzella F; Vaglio A; Garini G
Am J Med; 2010 May; 123(5):400-8. PubMed ID: 20399313
[TBL] [Abstract][Full Text] [Related]
35. [Extrahepatic manifestations related to hepatitis C virus].
Opolon P; Lunel F
Pathol Biol (Paris); 1995 Oct; 43(8):709-15. PubMed ID: 8745593
[TBL] [Abstract][Full Text] [Related]
36. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview.
Luppi M; Torelli G
Haematologica; 1996; 81(3):265-81. PubMed ID: 8767534
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].
Staak JO; Glossmann JP; Diehl V; Josting A
Med Klin (Munich); 2002 Oct; 97(10):601-8. PubMed ID: 12386793
[TBL] [Abstract][Full Text] [Related]
38. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
39. B-lymphoproliferative disorders in patients with hepatitis C virus infection.
Pérez Sánchez I; Rivera Redondo J; García Monforte A; Mayoayo Crespo M; Escudero Soto A; Pintado Cros T
Haematologica; 1998 Oct; 83(10):946-8. PubMed ID: 9830804
[TBL] [Abstract][Full Text] [Related]
40. HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies.
Ferri C; Giuggioli D; Cazzato M; Sebastiani M; Mascia MT; Zignego AL
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S78-84. PubMed ID: 14740431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
